News Column

SUNESIS PHARMACEUTICALS INC FILES (8-K) Disclosing Results of Operations and Financial Condition, Financial Statements and Exhibits

August 5, 2014



Item 2.02. Results of Operations and Financial Condition.

On August 5, 2014, we reported our financial results for the three months ended June 30, 2014. A copy of the press release issued concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

The press release is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by Sunesis, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. Exhibit No. Description 99.1 Press release, dated August 5, 2014, entitled "Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights."



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters